Iridex to Report Third Quarter 2021 Financial Results on November 11, 2021

Rhea-AI Summary

Iridex Corporation (NASDAQ: IRIX) will announce its Q3 2021 financial results after market close on November 11, 2021. The management team will conduct a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss the results. Interested investors can join the call by dialing (844) 707-0665 domestically or (703) 326-3030 internationally, using conference ID: 7496524. An archived webcast will be accessible on the Investors section of the company's website thereafter.

Positive

• Scheduled release of Q3 2021 financial results indicates transparency.
• Conference call provides investors with direct insights from management.

Negative

• None.

MOUNTAIN VIEW, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the third quarter of 2021 after the close of trading on Thursday, November 11, 2021. The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 7496524. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at: www.iridex.com.

About Iridex
Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit www.iridex.com.

Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investors@iridex.com

FAQ

When will Iridex release its Q3 2021 financial results?

Iridex will release its Q3 2021 financial results after the market closes on November 11, 2021.

What time is the Iridex conference call for Q3 2021 results?

The conference call will begin at 2:00 p.m. PT / 5:00 p.m. ET.

How can investors access the Iridex conference call?

Investors can dial (844) 707-0665 for domestic calls or (703) 326-3030 for international calls, using conference ID: 7496524.

Will there be a webcast of the Iridex Q3 2021 results conference call?

Yes, a live and archived webcast will be available on the Investors section of Iridex's website.